GenesysCapital_Logo
  • About
  • Team
  • Portfolio
  • News
  • LP Login
LP Login
Left arrow Icon
Back to News

World’s First Wearable Doppler Ultrasound Patch Expands to East Coast to Enhance Patient Safety at The Mount Sinai Hospital

17 Jun 2025
View Full Article

Latest

World’s First Wearable Doppler Ultrasound Patch Expands to East Coast to Enhance Patient Safety at The Mount Sinai Hospital

17 June 2025

Palisade Bio Reports Positive Phase 1a Results for PALI-2108, a First-in-Class Terminal Ileum and Colon-Targeted PDE4 B/D Inhibitor for Fibrostenotic Crohn’s Disease and Ulcerative Colitis

27 May 2025

Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy

29 April 2025

All Articles

June 17, 2025

World’s First Wearable Doppler Ultrasound Patch Expands to East Coast to Enhance Patient Safety at The Mount Sinai Hospital

Read More
June 11, 2025

Genesys Capital is closing its largest fund to date – Genesys Ventures IV LP

Read More
May 27, 2025

Palisade Bio Reports Positive Phase 1a Results for PALI-2108, a First-in-Class Terminal Ileum and Colon-Targeted PDE4 B/D Inhibitor for Fibrostenotic Crohn’s Disease and Ulcerative Colitis

Read More
April 29, 2025

Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy

Read More
See All
About
Team
Portfolio
News
Contact
GenesysCapital_Logo
123 Front Street West, Suite 1503
Toronto ON M5J 2M2
info@genesyscapital.com
Follow us on LinkedIn
Privacy Policy
© 2025 Genesys Capital. All rights reserved.